Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to molecular cancer biology in 2024, which are listed below:

1. “Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells”
by Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, David Horne, Ravi Salgia and Sharad S. Singhal
Cancers 2024, 16(13), 2478; https://doi.org/10.3390/cancers16132478
Available online: https://www.mdpi.com/2072-6694/16/13/2478

2. “The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics”
by Prathap Somu, Sonali Mohanty, Nagaraj Basavegowda, Akhilesh Kumar Yadav, Subhankar Paul and Kwang-Hyun Baek
Cancers 2024, 16(3), 638; https://doi.org/10.3390/cancers16030638
Available online: https://www.mdpi.com/2072-6694/16/3/638

3. “Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment”
by Mahmoud Singer, Zhuoli Zhang, Farshid Dayyani, Zigeng Zhang, Vahid Yaghmai, April Choi, Jennifer Valerin, David Imagawa and Nadine Abi-Jaoudeh
Cancers 2025, 17(1), 66; https://doi.org/10.3390/cancers17010066
Available online: https://www.mdpi.com/2072-6694/17/1/66

4. “Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications—A Literature Review”
by Mengjiao Wu, Chenjun Tian, Zhenwei Zou, Min Jin and Hongli Liu
Cancers 2024, 16(20), 3547; https://doi.org/10.3390/cancers16203547
Available online: https://www.mdpi.com/2072-6694/16/20/3547

5. “Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1”
by Ana Dillen, Indy Bui, Megan Jung, Stephanie Agioti, Apostolos Zaravinos and Benjamin Bonavida
Cancers 2024, 16(6), 1237; https://doi.org/10.3390/cancers16061237
Available online: https://www.mdpi.com/2072-6694/16/6/1237  

6. “Cisplatin Resistance and Metabolism: Simplification of Complexity”
by Nikolay V. Pervushin, Maria A. Yapryntseva, Mikhail A. Panteleev, Boris Zhivotovsky and Gelina S. Kopeina
Cancers 2024, 16(17), 3082; https://doi.org/10.3390/cancers16173082
Available online: https://www.mdpi.com/2072-6694/16/17/3082

7. “Aggressive Angiomyxoma of the Lower Female Genital Tract: A Review of the MITO Rare Tumors Group”
by Miriam Dellino, Francescapaola Magazzino, Lavinia Domenici, Stefania Cicogna, Salvatora Tindara Miano, Sandro Pignata, Giorgia Mangili and Gennaro Cormio
Cancers 2024, 16(7), 1375; https://doi.org/10.3390/cancers16071375
Available online: https://www.mdpi.com/2072-6694/16/7/1375

8. “Insight into Iron, Oxidative Stress and Ferroptosis: Therapy Targets for Approaching Anticancer Strategies”
by Marialuisa Piccolo, Maria Grazia Ferraro, Federica Iazzetti, Rita Santamaria and Carlo Irace
Cancers 2024, 16(6), 1220; https://doi.org/10.3390/cancers16061220
Available online: https://www.mdpi.com/2072-6694/16/6/1220

9. “The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance”
by Tyler A. Allen
Cancers 2024, 16(7), 1377; https://doi.org/10.3390/cancers16071377
Available online: https://www.mdpi.com/2072-6694/16/7/1377

10. “Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy”
by Mo-Fan Huang, Yuan-Xin Wang, Yu-Ting Chou and Dung-Fang Lee
Cancers 2024, 16(8), 1558; https://doi.org/10.3390/cancers16081558
Available online: https://www.mdpi.com/2072-6694/16/8/1558

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office